In a cross-sectional study examining late effects of pediatric sarcoma therapy, long-term survivors were evaluated on their activities of daily living (ADL) performance.
Differences in activities of daily living performance between long-term pediatric sarcoma survivors and a matched comparison group on standardized testing.